![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
Stroke prevention |
Rheumatoid Arthritis |
Free Subscription
11 Ann Rheum Dis |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Rheumatoid Arthritis is free of charge.
Safety of biological and targeted synthetic disease-modifying antirheumatic drugs
for rheumatoid arthritis as used in clinical practice: results from the ARTIS
programme.
Ann Rheum Dis. 2023 Feb 14:ard-2022-223762. doi: 10.1136/ard-2022-223762.
PubMed
Abstract available
Correction: EULAR recommendations for the management of rheumatoid arthritis with
synthetic and biological disease-modifying antirheumatic drugs: 2022 update.
Ann Rheum Dis. 2023;82:e76.
PubMed
News from EULAR.
Ann Rheum Dis. 2023;82:448.
PubMed
Deciphering the role of cDC2s in Sjogren's syndrome: transcriptomic profile links
altered antigen processes with IFN signature and autoimmunity.
Ann Rheum Dis. 2023;82:374-383.
PubMed
Abstract available
Correspondence on 'Interleukin 6 receptor inhibition in primary Sjogren syndrome:
a multicentre double-blind randomised placebo-controlled trial'.
Ann Rheum Dis. 2023;82:e67.
PubMed
Response to: 'Correspondence on 'Interleukin 6 receptor inhibition in primary
Sjogren syndrome: a multicentre double-blind randomised placebo-controlled
trial'' by Wang et al.
Ann Rheum Dis. 2023;82:e68.
PubMed
Correspondence on 'Risk factors for hospital admissions related to COVID-19 in
patients with autoimmune inflammatory rheumatic diseases'.
Ann Rheum Dis. 2023;82:e69.
PubMed
Response to: 'Correspondence on 'Risk factors for hospital admissions related to
COVID-19 in patients with autoimmune inflammatory rheumatic diseases'' by Aydin
et al.
Ann Rheum Dis. 2023;82:e70.
PubMed
Correspondence on 'Jan Gosta Waldenstrom and rheumatology'.
Ann Rheum Dis. 2023;82:e59.
PubMed
Correspondence on: 'EULAR definition of difficult-to-treat rheumatoid arthritis'.
Ann Rheum Dis. 2023;82:e55.
PubMed
Response to: 'Correspondence on 'EULAR definition of difficult-to-treat
rheumatoid arthritis'' by Novella-Navarro et al.
Ann Rheum Dis. 2023;82:e56.
PubMed
The efficacy and safety of olokizumab for rheumatoid arthritis: a systematic
review, pairwise, and network meta-analysis.
Clin Rheumatol. 2023 Feb 16. doi: 10.1007/s10067-023-06519.
PubMed
Abstract available
Prevalence and predictors of long-term remission in rheumatoid arthritis in
real-world practice: a longitudinal study.
Clin Rheumatol. 2023 Feb 17. doi: 10.1007/s10067-023-06548.
PubMed
Abstract available
Fibromyalgia and centralized pain in the rheumatoid arthritis patient.
Curr Opin Rheumatol. 2023 Feb 13. doi: 10.1097/BOR.0000000000000929.
PubMed
Abstract available
The impact of perioperative use of non-biologic disease-modifying anti-rheumatic
drugs on perioperative blood loss and complications in patients who have
rheumatoid arthritis undergoing total knee arthroplasty.
J Arthroplasty. 2023 Feb 8:S0883-5403(23)00079.
PubMed
Abstract available
Understanding Differences in Patient Descriptions of Rheumatoid Arthritis Flares
Using OMERACT Core Domains.
J Rheumatol. 2023 Feb 1:jrheum.211409. doi: 10.3899/jrheum.211409.
PubMed
Abstract available
Clinical outcomes of patients with rheumatoid arthritis who underwent
percutaneous coronary intervention: A Korean nationwide cohort study.
PLoS One. 2023;18:e0281067.
PubMed
Abstract available
Detecting hand joint ankylosis and subluxation in radiographic images using deep
learning: A step in the development of an automatic radiographic scoring system
for joint destruction.
PLoS One. 2023;18:e0281088.
PubMed
Abstract available
High-sensitivity cardiac troponin T is associated with disease activity in
patients with inflammatory arthritis.
PLoS One. 2023;18:e0281155.
PubMed
Abstract available
Antibody response in patients with autoimmune inflammatory rheumatic disease
after pneumococcal polysaccharide prime vaccination or revaccination.
Scand J Rheumatol. 2023;52:174-180.
PubMed
Abstract available
Complications after minor salivary gland biopsy: a retrospective study of 630
patients from two Swedish centres.
Scand J Rheumatol. 2023;52:208-216.
PubMed
Abstract available
Serum CCL28 as a biomarker for diagnosis and evaluation of Sjogren's syndrome.
Scand J Rheumatol. 2023;52:200-207.
PubMed
Abstract available
Thank you for your interest in scientific medicine.
This policy is made possible thanks to
a media sponsorship by